Page 1071 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 1071
CHAPTER 59 Special Aspects of Perinatal & Pediatric Pharmacology 1057
TABLE 59–6 Determination of drug dosage from Hansten PD, Horn JR: Drug Interactions, Analysis and Management. Facts &
surface area. 1 Comparisons. [Quarterly.]
International Liaison Committee on Resuscitation: The International Liaison
Committee on Resuscitation (ILCOR) consensus on science with treatment
Weight recommendations for pediatric and neonatal patients: pediatric basic and
Approximate Surface Percent of advanced life support. Pediatrics 2006;117:e955.
2
(kg) (lb) Age Area (m ) Adult Dose
Iqbal MM, Sohhan T, Mahmud SZ: The effects of lithium, valproic acid, and
3 6.6 Newborn 0.2 12 carbamazepine during pregnancy and lactation. J Toxicol Clin Toxicol
2001;39:381.
6 13.2 3 months 0.3 18 Ito S: Drug therapy for breast feeding women. N Engl J Med 2000;343:118.
10 22 1 year 0.45 28 Kearns GL et al: Developmental pharmacology—drug disposition, action and
20 44 5.5 years 0.8 48 therapy in infants and children. N Engl J Med 2003;349:1157.
Koren G: Medication Safety during Pregnancy and Breastfeeding; A Clinician’s Guide,
30 66 9 years 1 60 4th ed. McGraw-Hill, 2006.
40 88 12 years 1.3 78 Koren G, Nordeng H: Antidepressant use during pregnancy: The benefit-risk ratio.
Am J Obstet Gynecol 2012;207:157.
50 110 14 years 1.5 90
Koren G, Pastuszak A: Prevention of unnecessary pregnancy terminations by
60 132 Adult 1.7 102 counseling women on drug, chemical, and radiation exposure during the
first trimester. Teratology 1990;41:657.
70 154 Adult 1.76 103
Koren G, Pastuszak A, Ito E: Drugs in pregnancy. N Engl J Med 1998;
1 For example, if adult dose is 1 mg/kg, dose for 3-month-old infant would be 0.18 mg/kg 338:1128.
or 1.1 mg total. Koren G et al: Sex differences in the pharmacokinetics and bioequivalence of the
Reproduced, with permission, from Silver HK, Kempe CH, Bruyn HB: Handbook of delayed-release combination of doxylamine succinate-pyridoxine hydro-
Pediatrics, 14th ed. Originally published by Lange Medical Publications. © 1983 by the chloride: Implications for pharmacotherapy in pregnancy. J Clin Pharmacol
McGraw-Hill Companies, Inc. 2013;53:1268.
Madadi P et al: Pharmacogenetics of neonatal opioid toxicity following maternal
use of codeine during breastfeeding: A case control study. Clin Pharmacol
Despite these approximations, only by conducting studies in Ther 2009;85:31.
children can safe and effective doses for a given age group and Namouz-Haddad S, Koren G: Fetal pharmacotherapy 2: Fetal arrhythmia.
condition be determined. J Obstet Gynaecol Can 2013;35:1023.
Pauwels S, Allegaert K: Therapeutic drug monitoring in neonates. Arch Dis Child
2016;101:377.
REFERENCES Peled N et al: Gastric-outlet obstruction induced by prostaglandin therapy in
Briggs GG, Freeman RK, Yaffe SJ: Drugs in Pregnancy and Lactation: A Refer- neonates. N Engl J Med 1992;327:505.
ence Guide to Fetal and Neonatal Risk, 10th ed. Wolters Kluwer/Lippincott SickKids Drug Handbook and Formulary 2015/2016. The Hospital for Sick
Williams & Wilkins, 2015. Children, Toronto.
de Wildt SN et al: Ontogeny of midazolam glucuronidation in preterm infants. Tetelbaum M et al: Back to basics: Understanding drugs in children: Pharmacoki-
Eur J Clin Pharmacol 2010;66:165. netic maturation. Pediatr Rev 2005;26:321.
Gavin PJ, Yogev R: The role of protease inhibitor therapy in children with HIV Van Lingen RA et al: The effects of analgesia in the vulnerable infant during the
infection. Paediatr Drugs 2002;4:581. perinatal period. Clin Perinatol 2002;29:511.